PolyPid Ltd. logo

PYPD Earnings Date: Nov 11, 2026 (Estimated) — PolyPid Ltd.

NASDAQ · Healthcare · Biotechnology

Updated

Price $5.52
Market Cap $105.3M
P/E -3.5
52W Range $3.40 – $5.85
Next Earnings · Before open (est.)

When is PYPD's next earnings date?

PolyPid Ltd. (PYPD) is expected to report Q3 2026 earnings on Wednesday, November 11, 2026 at 7:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of $0.46 on revenue of $30.0M.

How did PYPD do in its last earnings report?

In its most recent report on Aug 12, 2026 (Q2 2026), PolyPid Ltd. posted EPS of -$0.35 versus the -$0.38 estimate, a beat of 5.4%. Revenue was $0 against a $300,000 estimate. The stock's 1-day post-earnings move was +2.3%.

How much does PYPD stock move after earnings?

PYPD beat EPS estimates in 4 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 2.6% (up or down) in the day after earnings.

About PolyPid Ltd.

PolyPid Ltd. is an advanced-stage biopharmaceutical company specializing in the development, manufacturing, and commercialization of therapeutic solutions. These solutions are based on its proprietary polymer-lipid encapsulation matrix (PLEX) platform, with the goal of addressing significant unmet medical needs. The company's leading product candidate, D-PLEX100, is currently undergoing Phase III clinical trials. It is being evaluated for its efficacy in preventing surgical site infections (SSIs) following both sternal (bone) and abdominal (soft tissue) procedures. Established in 2008, PolyPid Ltd. is headquartered in Petah Tikva, Israel.

Earnings History

DatePeriodEPS Est.EPS Act.SurpriseRevenueResult1D Δ1W Δ1M Δ
2026-08-12Q2 2026-0.38-0.35+5.41%$0✅ Beat+2.33%+0.00%+9.09%
2026-05-13Q1 2026-0.44-0.35+20.45%$0✅ Beat-7.46%+4.39%+0.22%
2026-02-11Q4 2025-0.33-0.41-24.24%$0❌ Miss-1.28%-9.19%-10.90%
2025-11-12Q3 2025-0.53-0.37+30.19%$0✅ Beat-0.27%-3.19%+5.85%
2025-08-13Q2 2025-0.54-0.78-44.44%$0❌ Miss+2.05%+3.22%+0.88%
2025-02-12Q4 2024-0.88-1.13-28.41%$0❌ Miss+2.95%+0.52%+1.91%
2024-11-13Q3 2024-1.00-1.22-22.00%$0❌ Miss-2.86%+2.86%-26.29%
2024-08-14Q2 2024-1.30-1.25+3.85%$0✅ Beat-1.97%+0.56%+0.84%

Showing last 8 quarters.

Related Companies

Learn More

Explore More

Financial data from licensed market-data providers; risk factors from SEC EDGAR filings. AI-powered analysis. Data last updated .